Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's Disease
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eli Lilly and Company
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT04570085 · Alzheimer Disease
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT06501495 · Aging, Alzheimer Disease
Hope Clinical Research, Inc.
Canoga Park, California
Neuro-Pain Medical Center
Fresno, California
Irvine Clinical Research
Irvine, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions